Alterity Therapeutics Share Price Today
(NASDAQ: ATHE)

Name: Alterity Therapeutics Share Price Today (NASDAQ: ATHE) - Alterity Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Alterity Therapeutics share price is $3.64 & ₹316.57 as on 6 Mar 2025, 2.30 'hrs' IST

$3.64

▲

0.08

(2.25%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Alterity Therapeutics share price in Dollar and Rupees. Guide to invest in Alterity Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Alterity Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Alterity Therapeutics share price movements

Today's Low: $3.51
Today's High: $3.74
$3.64
3.57%
Downside
Day's Volatility :6.15%
Upside
2.67%
52 Weeks Low: $1.00
52 Weeks High: $5.87
$3.64
72.5%
Downside
52 Weeks Volatility :82.95%
Upside
37.99%

Alterity Therapeutics (ATHE) Returns

Period	Alterity Therapeutics Ltd	Index (Russel 2000)
3 Months	83.51%	0.0%
6 Months	182.54%	0.0%
1 Year	108.19%	0.0%
3 Years	-51.44%	-11.6%

Alterity Therapeutics (ATHE) Key Statistics

in dollars & INR

Previous Close	$3.56
Open	$3.62
Today's High	$3.74
Today's Low	$3.51
Market Capitalization	$38.9M
Today's Volume	$426.0
52 Week High	$5.87
52 Week Low	$1.001
Revenue TTM	$4.0M
EBITDA	$-19.6M
Earnings Per Share (EPS)	$-6.63
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-104.47%

How to invest in Alterity Therapeutics Stock (ATHE) from India?

It is very easy for Indian residents to invest directly in Alterity Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Alterity Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Alterity Therapeutics or ATHE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Alterity Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Alterity Therapeutics shares which would translate to 0.239 fractional shares of Alterity Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Alterity Therapeutics, in just a few clicks!

Returns in Alterity Therapeutics (ATHE) for Indian investors in Rupees

The Alterity Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Alterity Therapeutics investment value today

Current value as on today

₹2,17,828

Returns

₹1,17,828

(+117.83%)

Returns from Alterity Therapeutics Stock

₹1,12,865 (+112.87%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Alterity Therapeutics (ATHE)

-56%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Alterity Therapeutics Stock from India on INDmoney has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Alterity Therapeutics

Morgan Stanley - Brokerage Accounts
0.42%
Point72 Asset Management, L.P.
0.31%
HB Wealth Management, LLC
0.30%
BNP Paribas Arbitrage, SA
0.08%
Twin Lakes Capital Management, LLC
0.06%

Analyst Recommendation on Alterity Therapeutics

Analyst Forecast on Alterity Therapeutics Stock (ATHE)

What analysts predicted

Upside of 202.2%

Target:

$11.00

Current:

$3.64

Insights on Alterity Therapeutics Stock (Ticker Symbol: ATHE)

Price Movement
In the last 7 days, ATHE stock has moved down by -14.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 690.71K → 2.11M (in $), with an average increase of 67.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -4.11M → -12.61M (in $), with an average decrease of 206.7% per quarter
ATHE vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 99.1%

ATHE Alterity Therapeutics Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$75.4K	↓ 46.05%
Net Income	$-8.6M	↑ 49.26%
Net Profit Margin	-11.4K%	↓ 7258.54%

	FY20	Y/Y Change
Revenue	$283.9K	↑ 279.19%
Net Income	$-6.9M	↓ 18.46%
Net Profit Margin	-2.4K%	↑ 8923.05%

	FY21	Y/Y Change
Revenue	$3.3M	↑ 954.41%
Net Income	$-11.7M	↑ 52.19%
Net Profit Margin	-352.78%	↑ 2091.46%

	FY22	Y/Y Change
Revenue	$3.6M	↑ 18.06%
Net Income	$-9.0M	↓ 16.08%
Net Profit Margin	-250.75%	↑ 102.03%

	FY23	Y/Y Change
Revenue	$2.6M	↓ 23.56%
Net Income	$-9.3M	↑ 7.47%
Net Profit Margin	-352.54%	↓ 101.79%

	FY24	Y/Y Change
Revenue	$2.7M	↑ 2.63%
Net Income	$-12.7M	↑ 38.51%
Net Profit Margin	-475.79%	↓ 123.25%

	Q4 FY22	Q/Q Change
Revenue	$1.6M	↑ 212.7%
Net Income	$-5.4M	↑ 212.7%
Net Profit Margin	-336.65%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	$1.0M	-
Net Income	$-3.9M	-
Net Profit Margin	-377.3%	-

	Q4 FY23	Q/Q Change
Revenue	$1.9M	↑ 24.19%
Net Income	$-6.5M	↑ 12.69%
Net Profit Margin	-342.35%	↑ 34.95%

	Q1 FY24	Q/Q Change
Revenue	$690.7K	↓ 63.66%
Net Income	$-4.1M	↓ 36.79%
Net Profit Margin	-595.51%	↓ 253.16%

	Q2 FY24	Q/Q Change
Revenue	$2.1M	↑ 206.72%
Net Income	$-12.6M	↑ 206.72%
Net Profit Margin	-595.51%	↑ 0.0%

	FY19	Y/Y Change
Profit	$-81.7K	↓ 436.41%

	FY20	Y/Y Change
Profit	$115.9K	↓ 242.87%

	FY21	Y/Y Change
Profit	$3.0M	↑ 2268.72%

	FY22	Y/Y Change
Profit	$3.3M	↑ 19.58%

	FY23	Y/Y Change
Profit	$2.4M	↓ 23.69%

	FY24	Y/Y Change
Profit	$2.5M	↑ 4.78%

	Q4 FY22	Q/Q Change
Profit	$1.6M	↑ 228.16%

	Q2 FY23	Q/Q Change
Profit	$993.1K	-

	Q4 FY23	Q/Q Change
Profit	$1.8M	↑ 23.58%

	Q1 FY24	Q/Q Change
Profit	$652.5K	↓ 64.28%

	Q2 FY24	Q/Q Change
Profit	$2.0M	↑ 213.42%

	FY19	Y/Y Change
Operating Cash Flow	$-9.7M	↑ 123.45%
Investing Cash Flow	$-4.9K	↓ 61.87%
Financing Cash Flow	$8.8M	↓ 11915.14%

	FY20	Y/Y Change
Operating Cash Flow	$-6.5M	↓ 32.42%
Investing Cash Flow	$-11.5K	↑ 138.45%
Financing Cash Flow	$2.7M	↓ 68.7%

	FY21	Y/Y Change
Operating Cash Flow	$-13.2M	↑ 83.75%
Investing Cash Flow	$-8.0K	↓ 37.46%
Financing Cash Flow	$28.0M	↑ 821.32%

	FY22	Y/Y Change
Operating Cash Flow	$-8.7M	↓ 28.81%
Investing Cash Flow	$-62.7K	↑ 751.29%
Financing Cash Flow	$11.5M	↓ 55.56%

	FY23	Y/Y Change
Operating Cash Flow	$-13.5M	↑ 62.4%
Investing Cash Flow	$-24.5K	↓ 59.1%
Financing Cash Flow	$83.5K	↓ 99.24%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-2.6M	↑ 15.56%
Investing Cash Flow	$-10.5K	↑ 547.48%
Financing Cash Flow	$83.5K	↓ 214.79%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$368.8K	↓ 114.06%
Investing Cash Flow	$-10.6K	↑ 0.0%
Financing Cash Flow	$-11.4K	↓ 113.6%

Alterity Therapeutics Technicals Summary

Sell

Neutral

Buy

Alterity Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Alterity Therapeutics (ATHE) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Alterity Therapeutics Ltd	-28.66%	182.54%	108.19%	-51.44%	-38.11%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Alterity Therapeutics Ltd	NA	NA	NA	-0.82	-1.04	-0.53	NA	0.0
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Alterity Therapeutics Ltd	NA	$38.9M	-38.11%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Alterity Therapeutics

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Organization	Alterity Therapeutics
Employees	10
CEO	Dr. David A. Stamler M.D.
Industry	Biotechnology

Management People of Alterity Therapeutics

Name	Title
Mr. Geoffrey Paul Kempler B.Sc.	Co-Founder & Non-Executive Chairman
Dr. David A. Stamler M.D.	Chief Executive Officer
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.	CFO & Company Secretary
Dr. Rudolph Emile Tanzi Ph.D.	Chief Scientific Advisor and Member of Research & Development Advisory Board
Dr. Steven D. Targum M.D.	Chief Medical Advisor
Dr. Robert Cherny	Head of Research

Important FAQs about investing in ATHE Stock from India :

What is Alterity Therapeutics share price today?

Alterity Therapeutics share price today stands at $3.64, Open: $3.62 ; Previous Close: $3.56 ; High: $3.74 ; Low: $3.51 ; 52 Week High: $5.87 ; 52 Week Low: $1.00.

The stock opens at $3.62, after a previous close of $3.56. The stock reached a daily high of $3.74 and a low of $3.51, with a 52-week high of $5.87 and a 52-week low of $1.00.

Can Indians buy Alterity Therapeutics shares?

Yes, Indians can invest in the Alterity Therapeutics (ATHE) from India.

With INDmoney, you can buy Alterity Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Alterity Therapeutics at zero transaction cost.

How can I buy Alterity Therapeutics shares from India?

It is very easy to buy Alterity Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Alterity Therapeutics (ATHE) be purchased?

Yes, you can buy fractional shares of Alterity Therapeutics with INDmoney app.

What are the documents required to start investing in Alterity Therapeutics stocks?

To start investing in Alterity Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.